Asia Pacific Drug Discovery Outsourcing Market Size & Outlook

The drug discovery outsourcing market in Asia Pacific is expected to reach a projected revenue of US$ 1,585.1 million by 2030. A compound annual growth rate of 8.5% is expected of Asia Pacific drug discovery outsourcing market from 2023 to 2030.
Revenue, 2022 (US$M)
$826.6
Forecast, 2030 (US$M)
$1,585.1
CAGR, 2023 - 2030
8.5%
Report Coverage
Asia Pacific

Asia Pacific drug discovery outsourcing market highlights

  • The Asia Pacific drug discovery outsourcing market generated a revenue of USD 826.6 million in 2022.
  • The market is expected to grow at a CAGR of 8.5% from 2023 to 2030.
  • In terms of segment, lead identification & candidate optimization was the largest revenue generating workflow in 2022.
  • Other Associated Workflow is the most lucrative workflow segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2023 to 2030.


Asia Pacific data book summary

Market revenue in 2022USD 826.6 million
Market revenue in 2030USD 1,585.1 million
Growth rate8.5% (CAGR from 2022 to 2030)
Largest segmentLead identification & candidate optimization
Fastest growing segmentOther Associated Workflow
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTarget Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow
Key market players worldwideAlbany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 23.3% of the global drug discovery outsourcing market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,585.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug Discovery Outsourcing Market Scope

Drug discovery outsourcing market segmentation & scope
Target Identification & Screening
Target Validation & Functional Informatics
Lead Identification & Candidate Optimization
Preclinical Development
Other Associated Workflow
Respiratory System
Pain and Anesthesia
Oncology
Ophthalmology
Hematology
Cardiovascular
Endocrine
Gastrointestinal
Immunomodulation
Anti-Infective
Central Nervous System
Dermatology
Genitourinary System
Small Molecules
Large Molecules (Biopharmaceuticals)

Drug Discovery Outsourcing Market Companies

Name Profile # Employees HQ Website

Asia Pacific drug discovery outsourcing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery outsourcing market will help companies and investors design strategic landscapes.


Lead identification & candidate optimization was the largest segment with a revenue share of 32.36% in 2022. Horizon Databook has segmented the Asia Pacific drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2018 to 2030.


Asia Pacific drug discovery outsourcing market is expected to witness the fastest growth over the forecast period. The emerging economies of Asian countries are a major factor contributing to the growth of this region as most of the patients in this region pay costs of pharmaceuticals out-of-pocket.

Ongoing studies in drug discovery, private-public collaborations, and government initiatives are some of the other factors likely to propel the growth of Asian drug discovery outsourcing market.

Reasons to subscribe to Asia Pacific drug discovery outsourcing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific drug discovery outsourcing market databook

  • Our clientele includes a mix of drug discovery outsourcing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific drug discovery outsourcing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific drug discovery outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific drug discovery outsourcing market outlook size, by country, 2018-2030 (US$M)

Asia Pacific Drug Discovery Outsourcing Market Outlook Share, 2022 & 2030 (US$M)

Asia Pacific drug discovery outsourcing market outlook size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more